Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002526385 | SCV000541658 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2016-10-31 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a RYR2-related disease. This variant does not occur within one of the three regions of the RYR2 gene (N-terminal domain, central domain or channel region) where other pathogenic variants have been reported to cluster (PMID: 19926015). In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). This sequence change replaces glycine with glutamic acid at codon 809 of the RYR2 protein (p.Gly809Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. |
All of Us Research Program, |
RCV004000612 | SCV004833268 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia | 2023-08-15 | criteria provided, single submitter | clinical testing |